Alzheimer's

News

Shionogi and Tetra expand partnership ahead of Alzheimer's t...

Shionogi has expanded its partnership with its Alzheimer’s drug development partner Tetra Therapeutics, giving an option for a buyout of the US biotech ahead of a key trial milestone.

News

engineering and genetic editing through the Crispr technique. DNA chain breaking down. 3D rendering

Biogen and Sangamo work on Parkinson's and Alzheimer's gene ...

Biogen and Sangamo have begun a collaboration to develop gene regulation therapies for neurological diseases including Parkinson’s and Alzheimer’s in a collaboration worth more than $2.7 bi

News

Warren Buffet shocks Wall Street with Biogen gamble

Biogen is trying to resurrect two failed trials of its Alzheimer’s drug aducanumab – and superstar investor Warren Buffet thinks the volatile stock is worth gambling on as the company prepa

Views & Analysis

Is Tecfidera’s patent win a pyrrhic victory for Biogen?

Shares in Biogen jumped last week after the company successfully defended its blockbuster MS drug Tecfidera from a patent challenge – but will the boost mean much when the company still fac

News

Closeup of X-ray photography of human brain

Roche and Lilly's Alzheimer's drugs draw blanks in inherited...

As Biogen prepares for an FDA review of its amyloid-targeting Alzheimer’s drug aducanumab, Roche and Eli Lilly lifted the lid on yet another trial failure involving two drugs aimed at this

News

Biogen gears up for Alzheimer's drug launch

There are serious doubts about whether the FDA will approve Biogen’s Alzheimer’s candidate aducanumab – but is gearing up to file it with the regulator and is already looking ahead to a pot

Shionogi and Tetra expand partnership ahead of Alzheimer's t...

Biogen and Sangamo work on Parkinson's and Alzheimer's gene ...

Warren Buffet shocks Wall Street with Biogen gamble

Is Tecfidera’s patent win a pyrrhic victory for Biogen?

Roche and Lilly's Alzheimer's drugs draw blanks in inherited...

Biogen gears up for Alzheimer's drug launch

AI specialists Enveda and Basecamp rake in the cash

Discover a new era of healthcare panel engagement: Grounded ...

Alzheimer's

Editor's Picks